We’re charting a new path to advance psychedelic medicine.

The research has spoken...

Psychedelics are here. The misunderstandings of the past have fallen away, as a new generation of healing becomes ready to establish a society of .

Through state legislation, starting in Oregon and Colorado, psilocybin, mescaline, ibogaine, and DMT services are entering the health & wellness marketplace.

A new era for mental wellness infrastructure is about to begin...

Through psychedelic service and healing centers, millions will have access to the most sophisticated, legal psychedelic modalities.

And with this, comes the need for a new generation of infrastructure to create modern consistency in:

  • 1.

    Compliance & record keeping

  • 2.

    Measurement & research protocols

  • 3.

    Best practices & safety procedures

  • 4.

    Supply chain & payment processing

  • 5.

    Privacy, equity, and accessibility

We have been building for this precise scenario for many years, and are ready to serve the new world...

Maya has built a unique foundation of trust, integrity, diplomacy, and technology, in our 4 years of work with the pioneers of this field.

Please join us on our journey to bring cutting edge technology systems to market, in support of a new era for mental health and wellness.

Our platform supports three major stakeholders:


We give researchers access to unique real world data that can inform clinical trial design and commercialization strategies, and optimize trial outcomes.

Learn more


We save providers time by automating screening, intake, preparation, and integration. Practice analytics inform greater health outcomes.

Learn more


We offer those receiving psychedelic therapy the opportunity to feel safe, gain insight into their healing journey, and learn about their own process.

Coming soon

World-renowned leaders have partnered with us.

Over the past few years, we’ve earned partnerships with some of the most innovative companies and organizations in the field.

Imperial College London logo
UCSF logo
Speak logo
Microdose Psychedelic Insights logo
Halugen logo
Myco meditations logo
The third wave logo
Wavepaths logo
Vote nature logo
Psychedelic Medicine Association logo
Lucid News logo
Sigmind logo
Naropa logo
Neuroscape logo
Heroic Hearts project logo
Mydecine logo
National Psychedelics Association logo

We are deeply rooted in the psychedelic and research community.

Our work stems from our background in academic research with Johns Hopkins University through Unlimited Sciences. Following our involvement helping Denver become the first city to decriminalize psilocybin mushrooms, we have become deeply connected with psychedelic practitioners and researchers all over the world.

About Us

There is much important work to be done in understanding how psychedelic medicines can be utilized safely while maximizing the benefit. I believe the work Maya and its team are doing is exceptional in this regard. It is exactly what is needed to help positively shape the industry while supporting us all to reach a greater stage in human development.

Dr. Dan Engle

Psychiatrist, Founder, Kuya Treatment Center

One of Maya’s major contributions is to make it more of the norm for practitioners to collect data, so they are able to demonstrate the value of psychedelic therapy.

Robin Carhart-Harris

Director of Psychedelics Division, Neuroscape, UCSF

Next arrow line grey icon
Prev arrow line grey icon

Read our last article

Read More

Listen our last podcast

Read More